FDA’s Relaxation of Four Data Elements

FDA’s reporting requirements are relaxed with respect to active ingredient producer for drugs; trade names for biologics, drugs, tobacco, radiation products; intended use reporting for certain products; and device listing number for medical devices and biologics.  See http://www.cbp.gov/sites/default/files/assets/documents/2016-Mar/FDA%20Webinar%20April%2023.pdf